June Cannabis Sales in 11 Markets Decrease Slightly From May to $1.65 Billion

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states.

Cannabis sales decreased 0.8% in June compared to May according to cannabis data analytics firm BDSA. Looking at a per-day basis, sales increased across all 11 states month-over-month. Compared to a year ago, sales were down in 7 markets, mostly driven by declining flower growth. In this review, we will look at the markets one-by-one, beginning with the eastern markets and then concluding with the western markets. In total, sales across the 11 markets totaled $1.65 billion during the month.

Eastern Markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan and Pennsylvania. In June, year-over-year growth ranged from -9% in Maryland to 23.5% in Florida and Michigan. Note that Florida, Maryland and Pennsylvania are medical-only markets.


In June, sales increased 3.2% sequentially to $192.4 million, up 23.5% from a year ago. Flower sales grew 20%, pre-rolls increased 13%, ingestibles gained 14% and concentrates expanded 37% year-over-year.


We previously published data released by the state showing that sales declined 3% from May and increased 5.4% from June 2021. BDSA estimated sales of $155.3 million, down 2.9% sequentially and up 5.4% from a year ago. Compared to last year, flower sales remained flat, pre-rolls jumped 36%, ingestibles grew 2% and concentrates increased 8%.


Sales fell 3% from May to $41 million, down 9% from a year ago. Flower sales decreased 10%, pre-rolls declined 9% and concentrates fell 13%, while ingestibles grew 6% year-over-year.


Sales grew 0.9% sequentially and 9.4% compared to a year ago to $145.4 million. Flower sales expanded 2%, pre-rolls expanded 29%, ingestibles increased 11% and concentrates grew 10%.


We had previously written about data released by the state indicating that Michigan cannabis sales gained 0.5% sequentially and 26% year-over-year. BDSA estimated sales of $187.4 million, up 0.5% sequentially and 23.5% from a year ago. Flower sales increased 16%, while concentrates grew 49%. Pre-rolls jumped 64% and ingestibles remained flat compared to prior year.


Sales fell 1.6% in June to $94.8 million, down 7.6% compared to a year ago. Flower sales declined 5% year-over-year, concentrates fell 11%, while ingestibles decreased 3%.

Western Markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In June, year-over-year growth ranged from -20.6% in Colorado to -5.1% in California compared to a year ago.


Combined sales of $106 million were down 2.7% from May and 10.1% compared to June 2021. Medical sales of $42.8 million were down 8% sequentially and 33% from a year ago. Adult-use sales of $63.1 million gained 1% from May and 18% year-over-year. Flower sales were down 24% from a year ago, while pre-rolls grew 35%. Concentrates fell 6% and ingestibles gained 6%.


California sales declined 2.5% sequentially to $431.3 million and fell 5.1% compared to a year ago. Flower sales were down 15%, while pre-rolls grew 12%. Ingestibles fell 4% and concentrates remained flat from a year ago during June.


Sales increased 0.6% in June compared to May, dropping 20.6% from a year ago to $148.8 million. Flower sales were down 24%, with pre-rolls and concentrates falling 16%. Ingestibles declined 22% year-over-year.


Sales increased 1.7% sequentially, falling 18.9% from a year ago to $66.4 million. Flower sales dropped 30% from a year ago. Concentrates fell 3%, while ingestibles decreased 12% and pre-rolls declined 15%.


Sales in June fell 2.3% from May to $82.7 million, down 17% from a year ago. Flower sales were down 30% year-over-year. Ingestibles grew 11%, while pre-rolls declined 5% and concentrates decreased 14%. 

For readers interested in a deeper look at cannabis markets across these eleven states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with unlimited access to the most accurate and actionable data and analysis.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter